Cart 0

QY Research

China Pancreatic Beta-Cell Protection Market Research Report 2017

$3,200.00

Report Published By: QY Research
Publication Date : Feb-17
No. Of Pages: 119

Notes:
Sales, means the sales volume of Pancreatic Beta-Cell Protection
Revenue, means the sales value of Pancreatic Beta-Cell Protection

This report studies Pancreatic Beta-Cell Protection in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
ViaCyte
PharmaCyte Biotech
Boehringer Ingelheim
GalaxoSmithKline
Beta-Cell NV
Novartis
Janssen Research & Development
Pfizer Inc
BioLineRx
Genentech
Novo Nordisk
Sanofi
Osiris Therapeutics
Beta-O2 Technologies Ltd
Transition Therapeutics

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Stem Cell Based
Gene Therapies
RNA Based Therapies
Monoclonal Antibodies (MAbs)
Phytotherapy
Split by Application, this report focuses on consumption, market share and growth rate of Pancreatic Beta-Cell Protection in each application, can be divided into
Hospital
Medical Research Laboratory
Others

Table of Contents

China Pancreatic Beta-Cell Protection Market Research Report 2017
1 Pancreatic Beta-Cell Protection Market Overview
1.1 Product Overview and Scope of Pancreatic Beta-Cell Protection
1.2 Pancreatic Beta-Cell Protection Segment by Type
1.2.1 China Production Market Share of Pancreatic Beta-Cell Protection Type in 2015
1.2.2 Stem Cell Based
1.2.3 Gene Therapies
1.2.4 RNA Based Therapies
1.2.5 Monoclonal Antibodies (MAbs)
1.2.6 Phytotherapy
1.3 Applications of Pancreatic Beta-Cell Protection
1.3.1 Pancreatic Beta-Cell Protection Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 China Market Size (Value) of Pancreatic Beta-Cell Protection (2012-2022)
1.5 China Pancreatic Beta-Cell Protection Status and Outlook
1.6 Government Policies

2 China Pancreatic Beta-Cell Protection Market Competition by Manufacturers
2.1 China Pancreatic Beta-Cell Protection Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Pancreatic Beta-Cell Protection Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Pancreatic Beta-Cell Protection Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Pancreatic Beta-Cell Protection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pancreatic Beta-Cell Protection Market Competitive Situation and Trends
2.5.1 Pancreatic Beta-Cell Protection Market Concentration Rate
2.5.2 Pancreatic Beta-Cell Protection Market Share of Top 3 and Top 5 Manufacturers

3 China Pancreatic Beta-Cell Protection Manufacturers Profiles/Analysis
3.1 ViaCyte
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.1.2.1 Stem Cell Based
3.1.2.2 Gene Therapies
3.1.3 ViaCyte Pancreatic Beta-Cell Protection Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 PharmaCyte Biotech
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.2.2.1 Stem Cell Based
3.2.2.2 Gene Therapies
3.2.3 PharmaCyte Biotech 119 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Boehringer Ingelheim
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.3.2.1 Stem Cell Based
3.3.2.2 Gene Therapies
3.3.3 Boehringer Ingelheim 129 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 GalaxoSmithKline
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.4.2.1 Stem Cell Based
3.4.2.2 Gene Therapies
3.4.3 GalaxoSmithKline Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Beta-Cell NV
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.5.2.1 Stem Cell Based
3.5.2.2 Gene Therapies
3.5.3 Beta-Cell NV Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Novartis
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.6.2.1 Stem Cell Based
3.6.2.2 Gene Therapies
3.6.3 Novartis Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Janssen Research & Development
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.7.2.1 Stem Cell Based
3.7.2.2 Gene Therapies
3.7.3 Janssen Research & Development Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Pfizer Inc
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.8.2.1 Stem Cell Based
3.8.2.2 Gene Therapies
3.8.3 Pfizer Inc Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 BioLineRx
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.9.2.1 Stem Cell Based
3.9.2.2 Gene Therapies
3.9.3 BioLineRx Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Genentech
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Pancreatic Beta-Cell Protection Product Type, Application and Specification
3.10.2.1 Stem Cell Based
3.10.2.2 Gene Therapies
3.10.3 Genentech Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Novo Nordisk
3.12 Sanofi
3.13 Osiris Therapeutics
3.14 Beta-O2 Technologies Ltd
3.15 Transition Therapeutics

4 China Pancreatic Beta-Cell Protection Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Pancreatic Beta-Cell Protection Capacity, Production and Growth (2012-2017)
4.2 China Pancreatic Beta-Cell Protection Revenue and Growth (2012-2017)
4.3 China Pancreatic Beta-Cell Protection Production, Consumption, Export and Import (2012-2017)

5 China Pancreatic Beta-Cell Protection Production, Revenue (Value), Price Trend by Type
5.1 China Pancreatic Beta-Cell Protection Production and Market Share by Type (2012-2017)
5.2 China Pancreatic Beta-Cell Protection Revenue and Market Share by Type (2012-2017)
5.3 China Pancreatic Beta-Cell Protection Price by Type (2012-2017)
5.4 China Pancreatic Beta-Cell Protection Production Growth by Type (2012-2017)

6 China Pancreatic Beta-Cell Protection Market Analysis by Application
6.1 China Pancreatic Beta-Cell Protection Consumption and Market Share by Application (2012-2017)
6.2 China Pancreatic Beta-Cell Protection Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaPancreatic Beta-Cell Protection Market Analysis by Regions (Provinces)
7.1 China Pancreatic Beta-Cell Protection Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Pancreatic Beta-Cell Protection Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Pancreatic Beta-Cell Protection Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Pancreatic Beta-Cell Protection Sales Price by Regions (Provinces)(2012-2017)
7.2 China Pancreatic Beta-Cell Protection Consumption by Regions (Provinces)(2012-2017)
7.3 China Pancreatic Beta-Cell Protection Production, Consumption, Export and Import (2012-2017)

8 Pancreatic Beta-Cell Protection Manufacturing Cost Analysis
8.1 Pancreatic Beta-Cell Protection Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pancreatic Beta-Cell Protection

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pancreatic Beta-Cell Protection Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pancreatic Beta-Cell Protection Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Pancreatic Beta-Cell Protection Market Forecast (2017-2022)
12.1 China Pancreatic Beta-Cell Protection Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Pancreatic Beta-Cell Protection Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Pancreatic Beta-Cell Protection Production Forecast by Type (2017-2022)
12.4 China Pancreatic Beta-Cell Protection Consumption Forecast by Application (2017-2022)
12.5 China Pancreatic Beta-Cell Protection Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Pancreatic Beta-Cell Protection Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Pancreatic Beta-Cell Protection Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Pancreatic Beta-Cell Protection Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Pancreatic Beta-Cell Protection Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


* indicates required information

* indicates required information


Share this Product


More from this collection